These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 37458730)

  • 1. Investigating the Unbinding of Muscarinic Antagonists from the Muscarinic 3 Receptor.
    Buigues PJ; Gehrke S; Badaoui M; Dudas B; Mandana G; Qi T; Bottegoni G; Rosta E
    J Chem Theory Comput; 2023 Aug; 19(15):5260-5272. PubMed ID: 37458730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease.
    Disse B; Speck GA; Rominger KL; Witek TJ; Hammer R
    Life Sci; 1999; 64(6-7):457-64. PubMed ID: 10069510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease.
    Barnes PJ; Belvisi MG; Mak JC; Haddad EB; O'Connor B
    Life Sci; 1995; 56(11-12):853-9. PubMed ID: 10188785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative characterization of lung muscarinic receptor binding after intratracheal administration of tiotropium, ipratropium, and glycopyrrolate.
    Ogoda M; Niiya R; Koshika T; Yamada S
    J Pharmacol Sci; 2011; 115(3):374-82. PubMed ID: 21358117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tiotropium on COPD exacerbations: A systematic review.
    Halpin DM; Vogelmeier C; Pieper MP; Metzdorf N; Richard F; Anzueto A
    Respir Med; 2016 May; 114():1-8. PubMed ID: 27109805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic receptor signaling in the pathophysiology of asthma and COPD.
    Gosens R; Zaagsma J; Meurs H; Halayko AJ
    Respir Res; 2006 May; 7(1):73. PubMed ID: 16684353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tiotropium bromide, a new, once-daily inhaled anticholinergic bronchodilator for chronic-obstructive pulmonary disease.
    ZuWallack AR; ZuWallack RL
    Expert Opin Pharmacother; 2004 Aug; 5(8):1827-35. PubMed ID: 15264997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why choose tiotropium for my patient? A comprehensive review of actions and outcomes versus other bronchodilators.
    Halpin DM; Kaplan AG; Russell RK
    Respir Med; 2017 Jul; 128():28-41. PubMed ID: 28610667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiotropium – what role in asthma?
    Drug Ther Bull; 2015 Sep; 53(9):102-4. PubMed ID: 26358316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of Tiotropium/Olodaterol Compared with Tiotropium in Patients with COPD Receiving only LAMA at Baseline: Pooled Analysis of the TONADO
    Buhl R; Singh D; de la Hoz A; Xue W; Ferguson GT
    Adv Ther; 2020 Aug; 37(8):3485-3499. PubMed ID: 32462607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiotropium increases PPARγ and decreases CREB in cells isolated from induced sputum of COPD patients.
    Holownia A; Mroz RM; Skopinski T; Kolodziejczyk A; Chyczewska E; Braszko JJ
    Adv Exp Med Biol; 2013; 756():9-14. PubMed ID: 22836613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ; Keating GM
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affirmation of the adoration of the vagi and role of tiotropium in asthmatic patients.
    Gelb AF; Nadel JA
    J Allergy Clin Immunol; 2016 Oct; 138(4):1011-1013. PubMed ID: 27527265
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
    Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Muscarinic cholinergic receptor antagonists enhanced the expression of CD(8)(+)CD(25)(+)Foxp(3)(+) regulatory T cells in stable COPD patients].
    Zhang JC; Wang P; Xiong XZ; Deng L; Xin JB; Ma WL; Shi HZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jan; 33(1):33-6. PubMed ID: 20368022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evaluation of long-acting muscarinic antagonists: comparison of tiotropium and investigational drugs.
    Casarosa P; Bouyssou T; Germeyer S; Schnapp A; Gantner F; Pieper M
    J Pharmacol Exp Ther; 2009 Aug; 330(2):660-8. PubMed ID: 19478135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Tiotropium/Olodaterol Compared with Tiotropium as a First-Line Maintenance Treatment in Patients with COPD Who Are Naïve to LAMA, LABA and ICS: Pooled Analysis of Four Clinical Trials.
    Buhl R; de la Hoz A; Xue W; Singh D; Ferguson GT
    Adv Ther; 2020 Oct; 37(10):4175-4189. PubMed ID: 32671684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aclidinium bromide for the treatment of chronic obstructive pulmonary disease.
    Gupta V; Singh D
    Expert Rev Respir Med; 2012 Dec; 6(6):581-8. PubMed ID: 23234445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term general and cardiovascular safety of tiotropium/olodaterol in patients with moderate to very severe chronic obstructive pulmonary disease.
    Buhl R; Magder S; Bothner U; Tetzlaff K; Voß F; Loaiza L; Vogelmeier CF; McGarvey L
    Respir Med; 2017 Jan; 122():58-66. PubMed ID: 27993292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term safety of glycopyrrolate/eFlow
    Ferguson GT; Goodin T; Tosiello R; Wheeler A; Kerwin E
    Respir Med; 2017 Nov; 132():251-260. PubMed ID: 28919143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.